Literature DB >> 24899750

Prenatal chromosomal microarray for the Catholic physician.

Jay J Bringman1.   

Abstract

Prenatal chromosomal microarray (CMA) is a test that is used to diagnose certain genetic problems in the fetus. While the test has been used in the pediatric setting for several years, it is now being introduced for use in the prenatal setting. The test offers great hope for detection of certain genetic defects in the fetus so that early intervention can be performed to improve the outcome for that individual. As with many biotechnical advances, CMA comes with certain bioethical issues that need to be addressed prior to its implementation. This paper is intended to provide guidance to all those that provide counseling regarding genetic testing options during pregnancy.

Entities:  

Keywords:  Chromosomal microarray; Prenatal diagnosis

Year:  2014        PMID: 24899750      PMCID: PMC4028733          DOI: 10.1179/2050854914Y.0000000019

Source DB:  PubMed          Journal:  Linacre Q        ISSN: 0024-3639


  23 in total

1.  Evangelium Vitae.

Authors: 
Journal:  Origins       Date:  1995-04-06

2.  Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting.

Authors:  Idit Maya; Bella Davidov; Liron Gershovitz; Yael Zalzstein; Ellen Taub; Justine Coppinger; Lisa G Shaffer; Mordechai Shohat
Journal:  Prenat Diagn       Date:  2010-12       Impact factor: 3.050

Review 3.  Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability.

Authors:  Jacques S Beckmann; Xavier Estivill; Stylianos E Antonarakis
Journal:  Nat Rev Genet       Date:  2007-08       Impact factor: 53.242

Review 4.  Consultation with the specialist. The vulnerable child.

Authors:  L K Leslie; W T Boyce
Journal:  Pediatr Rev       Date:  1996-09

Review 5.  Genomics and perinatal care.

Authors:  Joann Bodurtha; Jerome F Strauss
Journal:  N Engl J Med       Date:  2012-01-05       Impact factor: 91.245

6.  Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing.

Authors:  George McGillivray; Jill A Rosenfeld; R J McKinlay Gardner; Lynn H Gillam
Journal:  Prenat Diagn       Date:  2012-04       Impact factor: 3.050

Review 7.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

8.  A randomized trial of prenatal versus postnatal repair of myelomeningocele.

Authors:  N Scott Adzick; Elizabeth A Thom; Catherine Y Spong; John W Brock; Pamela K Burrows; Mark P Johnson; Lori J Howell; Jody A Farrell; Mary E Dabrowiak; Leslie N Sutton; Nalin Gupta; Noel B Tulipan; Mary E D'Alton; Diana L Farmer
Journal:  N Engl J Med       Date:  2011-02-09       Impact factor: 91.245

9.  Application of a target array comparative genomic hybridization to prenatal diagnosis.

Authors:  Ji Hyeon Park; Jung Hoon Woo; Sung Han Shim; Song-Ju Yang; Young Min Choi; Kap-Seok Yang; Dong Hyun Cha
Journal:  BMC Med Genet       Date:  2010-06-24       Impact factor: 2.103

Review 10.  Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects.

Authors:  Gurdeep S Sagoo; Adam S Butterworth; Simon Sanderson; Charles Shaw-Smith; Julian P T Higgins; Hilary Burton
Journal:  Genet Med       Date:  2009-03       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.